weight regain tirzepatide after the withdrawal of (Zepbound) may wipe out many of the cardiometabolic gains made during weight loss, a post-hoc analysis of the SURMOUNT-4 trial indicated. Read more at: https://www.medpagetoday.com/endocrinology/obesity Weight regain and cardiometabolic effects
Description
10.2337/dc19-s011 9 ChangK
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity
Over-the-counter hydrocortisone cream (1%) applied to the area can help with persistent itching
Others drop 3 to 4 pounds, mostly from reduced food intake and some water weight redistribution
As governments and insurers recognize the economic and healthcare burden of obesity, coverage and accessibility are set to improve, further accelerating market adoption
Il medicinale indicato per persone con obesit e in sovrappeso in presenza di almeno una comorbidit (e in aggiunta a dieta ipocalorica e attivit fisica) e diabete di tipo 2 non controllato, ed disponibile come trattamento di classe CNN (classe C non negoziata)
